1. Home
  2. TMCI

as of 12-02-2025 3:59pm EST

$2.70
$0.14
-4.77%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Chart Type:
Time Range:
Founded: 2014 Country:
United States
United States
Employees: N/A City: PONTE VEDRA
Market Cap: 401.8M IPO Year: 2021
Target Price: $7.07 AVG Volume (30 days): 1.2M
Analyst Decision: Hold Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.80 EPS Growth: N/A
52 Week Low/High: $2.56 - $10.79 Next Earning Date: 11-06-2025
Revenue: $218,879,000 Revenue Growth: 7.90%
Revenue Growth (this year): 3.25% Revenue Growth (next year): 1.07%

AI-Powered TMCI Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.17%
75.17%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: